The global cell counting market is poised for substantial growth during forecast period 2024 to 2031. As of 2024, the market is estimated to reach a valuation of US$19 Billion, a significant increase from US$9 Billion in 2024. The escalating prevalence of infectious and chronic diseases worldwide, coupled with advancements in cell counting technology, is fueling this impressive growth.
The growing utilization of cell counting equipment and supplies across various sectors, including research, healthcare, and industrial applications, is a key driver of market growth. Electronic cell counting devices are increasingly being used in fields such as cancer biology, immunology, and neurology, offering exponential growth prospects.
Biotechnology and pharmaceutical industries are expected to experience significant growth, further boosting the demand for cell counting. Government initiatives to support cell therapy research and increased funding for stem cell research in multiple countries are expediting market growth.
The introduction of innovative products, such as reusable 3D cell culture microplates, is expected to stimulate market growth. Researchers can use these plates to create embryoid bodies, a crucial step in developing larger organoids or spheroids from stem cells.
Production and sourcing constraints in the bioprocessing of biologics using cell counting techniques could pose a significant challenge to adoption in the coming years.
The stem cell research application segment is projected to exhibit the fastest CAGR during the forecast period, driven by the increasing demand for stem cells in transplantation, cancer treatment, and tissue regeneration.
Europe: The robust healthcare infrastructure in major European economies and a growing elderly population drive demand for cell counting technology. The UK is expected to be a lucrative market in the region.
South Korea: Increasing clinical research and biopharmaceutical businesses in the Asia-Pacific region boost domestic demand for cell counting devices, providing growth opportunities in the South Korean market.
Japan: Japan's role as a manufacturing and exporting hub for electronic equipment has created opportunities for regional market players, particularly in exporting cell counting devices.
This product will be delivered within 1-3 business days.
Factors Propelling the Global Cell Counting Market
The COVID-19 pandemic had a profound impact on the global cell counting market, with increased demand for cell counting technology to detect infections and monitor health conditions. The pandemic highlighted the importance of cell counting in diagnosing diseases like COVID-19, osteopenia, and lymphopenia. Consequently, it played a pivotal role in shaping the market's trends and opportunities.The growing utilization of cell counting equipment and supplies across various sectors, including research, healthcare, and industrial applications, is a key driver of market growth. Electronic cell counting devices are increasingly being used in fields such as cancer biology, immunology, and neurology, offering exponential growth prospects.
Biotechnology and pharmaceutical industries are expected to experience significant growth, further boosting the demand for cell counting. Government initiatives to support cell therapy research and increased funding for stem cell research in multiple countries are expediting market growth.
Prevailing Opportunities in the Global Cell Counting Market
The rising incidence of infectious and chronic diseases, technical advancements, and new product releases are expected to propel the global cell counting market. Automated cell counters have made it easier to determine stem cell viability and nucleated cell content, offering lucrative opportunities for both existing and new healthcare equipment manufacturers.The introduction of innovative products, such as reusable 3D cell culture microplates, is expected to stimulate market growth. Researchers can use these plates to create embryoid bodies, a crucial step in developing larger organoids or spheroids from stem cells.
Factors Hampering the Global Cell Counting Market
The high cost of hemocytometers and disposable cell counters is anticipated to limit market opportunities. Additionally, the elevated prices of sophisticated cell counting methods and product recalls related to hematology analyzers may restrain market trends.Production and sourcing constraints in the bioprocessing of biologics using cell counting techniques could pose a significant challenge to adoption in the coming years.
Dominating Market Segments
In the component segment, consumables and accessories contribute over 50% of the total revenue, with reagents, microplates, instruments, magnetic beads, and chamber slides being the highest contributing sub-segments. The instruments section is also expected to maintain a significant share in terms of value.Leading Market Segments by Application
The whole blood count segment holds the highest share, with over 55% of total revenue generated annually. The need to monitor various blood components in the context of blood illnesses like leukemia and anemia drives the growth of this segment.The stem cell research application segment is projected to exhibit the fastest CAGR during the forecast period, driven by the increasing demand for stem cells in transplantation, cancer treatment, and tissue regeneration.
Country-wise Insights
United States: North America dominates the global cell counting market, with the United States leading in sales and usage of cell counting machines. Factors such as a growing incidence of chronic diseases, blood plasma disorders, and cardiovascular conditions contribute to the market's expansion.Europe: The robust healthcare infrastructure in major European economies and a growing elderly population drive demand for cell counting technology. The UK is expected to be a lucrative market in the region.
South Korea: Increasing clinical research and biopharmaceutical businesses in the Asia-Pacific region boost domestic demand for cell counting devices, providing growth opportunities in the South Korean market.
Japan: Japan's role as a manufacturing and exporting hub for electronic equipment has created opportunities for regional market players, particularly in exporting cell counting devices.
Competitive Landscape
Key players in the global cell counting market include:
- ThermoFisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies
- PerkinElmer, Inc.
- BD
- Danaher
- Bio-Rad Laboratories, Inc.
- BioTek Instruments, Inc.
- GE Healthcare
- DeNovix Inc.
Key Segments Covered in the Global Cell Counting Industry Report
Global Cell Counting Market by Product
- Cell Counting Instruments
- Spectrophotometers
- Flow Cytometers
- Hemocytometers
- Automated Cell Counters
- Microscopes
- Others
- Cell Counting Consumables & Accessories
- Reagents
- Microplates
- Others
Global Cell Counting Market by Application
- Cell Counting for Complete Blood Count
- Automated Cell Counters
- Manual Cell Counters
- Cell Counting for Stem Cell Research
- Cell Counting for Cell Based Therapeutics
- Cell Counting for Bioprocessing
- Cell Counting for Toxicology
- Others
Global Cell Counting by End User
- Global Cell Counting in Hospitals & Diagnostic Laboratories
- Global Cell Counting in Research & Academic Institutes
- Global Cell Counting in Pharmaceutical & Biotechnology Companies
- Others
Global Cell Counting Market by Region
- North America Cell Counting Market
- Europe Cell Counting Market
- Asia-Pacific Cell Counting Market
- Middle East & Africa Cell Counting Market
- South America Cell Counting Market
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Cell Counting Market Outlook, 2018 - 2031
4. North America Cell Counting Market Outlook, 2018 - 2031
5. Europe Cell Counting Market Outlook, 2018 - 2031
6. Asia Pacific Cell Counting Market Outlook, 2018 - 2031
7. Latin America Cell Counting Market Outlook, 2018 - 2031
8. Middle East & Africa Cell Counting Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ThermoFisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies
- PerkinElmer, Inc.
- BD
- Danaher
- Bio-Rad Laboratories, Inc.
- BioTek Instruments, Inc.
- GE Healthcare
- DeNovix Inc.
Methodology
LOADING...
